Regd. Office: Dr Lal ParnLabs tid, Mode, Sector-14, Robin, New Deté-1 1000
‘Webs wiv. Lapatnitibs com, CIN: L7409908 1 995710065 308

: Malo
: 17/4/2025 6:56:41AM

: DR SAMEER GUPTA

: | 4:50:00AM

=

Collected :
Alc Status :P ‘atus ; Final
Collected at: ASHIRVAD MULTI SPECIALITY HOSPITAL Processed at; Or, Lal Path Labs Ltd
Mahmoor Gan}, Ashirvad Hospital, Varanas! - Mahmoorganj ,Varanasi - 221010
2210010
Test Report
BILIRUBIN TOTAL, DIRECT AND INDIRECT, SERUM
| (Diazo)
| Bilirubin Total 10.95 mg/dL 1,50 - 12.00
Bilirubin Direct ‘ 0.35 mg/dL 0.00 - 0.40
| Bilirubin Indirect 10.60 mg/dL <1.10

Comment

Unconjugated hyperbilirubinemia poses a risk for development of Kernicterus, especially in low birth weight
infants. Most neonates develop mild unconjugated hyperbilirubinemia between days 2and Safter birth. Peak
levels are typically 5-10 mg/dL and decline to normal level within 2 weeks. It is recommended to interpret
bilirubin levels according to infant's ay Hil EE SS ES ES
concentration above 10 mg/dL coupled with prematurity, low serum albumin, acidosis, and substances that
complete with binding site albumin (eg. ceftriaxone, sulfisoxarole, aspirin), may increase the risk for

Kemicterus.

| C-REACTIVE PROTEIN; CRP, SERUM 6.50 mg/L <6.00

| (Immunoturbidimetry)

a

UO UL rape 36
